Susanne K. Pedersen
Bedford Park, SA 5042, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Investigation of a methylated BCAT1 and IKZF1 circulating tumour DNA blood test for monitoring treatment response in patients with colorectal cancer.
Journal: Journal of cancer research and clinical oncology
Published: April 03, 2026
Improving detection of colorectal cancer: A Bayesian approach to serial circulating tumour DNA testing following curative-intent treatment.
Journal: Clinical and translational medicine
Published: March 15, 2026
Assessment of methylated BCAT1 and IKZF1 circulating tumor DNA as a prognostic biomarker in esophagogastric adenocarcinomas.
Journal: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus
Published: October 13, 2025
Effect of chemoradiation treatment on methylated BCAT1 and IKZF1 in rectal cancer.
Journal: International journal of cancer
Published: March 23, 2025
A blood test measuring DNA methylation of BCAT1 and IKZF1 for detection of lung adenocarcinoma.
Journal: Cancer treatment and research communications
Published: March 26, 2024
Evaluating the Role of Methylated Circulating Tumor DNA in Combination With Pathological Prognostic Factors for Predicting Recurrence of Colorectal Cancer.
Journal: Biomarker insights
Published: February 19, 2023
Detection of methylated BCAT1 and IKZF1 after curative-intent treatment as a prognostic indicator for colorectal cancer recurrence.
Journal: Cancer medicine
Published: May 02, 2022
Detection of hypermethylated BCAT1 and IKZF1 DNA in blood and tissues of colorectal, breast and prostate cancer patients.
Journal: Cancer biomarkers : section A of Disease markers
Published: March 07, 2022
Detection of recurrent colorectal cancer with high specificity using a reporting threshold for circulating tumor DNA methylated in BCAT1 and IKZF1.
Journal: Cancer
Published: November 28, 2021
Assessment of tumor burden and response to therapy in patients with colorectal cancer using a quantitative ctDNA test for methylated BCAT1/IKZF1.
Journal: Molecular oncology
Published: July 30, 2021
Evaluation of a panel of tumor-specific differentially-methylated DNA regions in IRF4, IKZF1 and BCAT1 for blood-based detection of colorectal cancer.
Journal: Clinical epigenetics
Published: November 04, 2020
Evaluation of Circulating Tumor DNA for Methylated BCAT1 and IKZF1 to Detect Recurrence of Stage II/Stage III Colorectal Cancer (CRC).
Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Published: June 03, 2020
Last Updated: 09/26/2026